Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedNew revision entry v3.6.3 was added to the study's history, replacing the previous v3.6.2. This reflects an update to the revision history metadata rather than changes to the study content.SummaryDifference0.1%

- Check21 days agoChange DetectedThe record history shows a new revision label of v3.6.2, replacing the previous v3.6.0. This reflects an updated version of the study record.SummaryDifference0.1%

- Check35 days agoChange DetectedA new entry for Revision: v3.6.0 has been added to the revision history, signaling an updated study record version. The older Revision: v3.5.5 entry has been removed from the history.SummaryDifference0.5%

- Check42 days agoChange DetectedThe revision history now lists the latest release as v3.5.5, replacing the previous v3.5.4.SummaryDifference0.1%

- Check64 days agoChange DetectedThe revision label on the page updated from v3.5.3 to v3.5.4, indicating a new version of the study record history.SummaryDifference0.1%

- Check86 days agoChange DetectedUpdate of the ClinicalTrials.gov page revision indicator from “v3.5.2” to “v3.5.3,” reflecting a platform/version change without altering the study’s recorded content.SummaryDifference0.1%

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.